JonesTrading Initiates Coverage On Perspective Therapeutics with Buy Rating, Announces Price Target of $1.4
Portfolio Pulse from Benzinga Newsdesk
JonesTrading analyst Justin Walsh has initiated coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and set a price target of $1.4.
November 15, 2023 | 10:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JonesTrading has initiated coverage on Perspective Therapeutics with a Buy rating and a price target of $1.4.
The initiation of coverage by JonesTrading with a Buy rating typically indicates a positive outlook on the stock, suggesting that the analyst sees potential upside. The announcement of a price target higher than the current trading price can often lead to increased investor interest and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100